Increased transendothelial permeability of anti-cancer agent carboplatin with the aid of hyperbaric oxygenation

Xenobiotica

Volumn 38, Issue 10, 2008, Pages 1298-1304

  Yamazaki, H ^a   Shimizu, M ^a   Murayama, N ^a   Tanaka, K ^b   Nion, S ^c   Cecchelli, R ^d  

^a SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c CELLIAL Technologies   (France)

^d UNIVERSITÉ D'ARTOIS   (France)

Author keywords

Anti cancer drug; Brain; Carboplatin; Hyperbaric oxygenation; Transport

Indexed keywords

CARBOPLATIN; DOXORUBICIN; GLYCOPROTEIN P; LUCIFER YELLOW; VERAPAMIL;

ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN TUMOR; CONTROLLED STUDY; COW; DRUG EFFICACY; DRUG PENETRATION; DRUG TRANSPORT; ENDOTHELIUM CELL; HYPERBARIC OXYGEN; IN VITRO STUDY; NONHUMAN; PROTEIN FUNCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD-BRAIN BARRIER; CAPILLARY PERMEABILITY; CARBOPLATIN; CATTLE; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HYPERBARIC OXYGENATION; RATS;

BOVINAE;

EID: 53849105129     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.1080/00498250802405472     Document Type: Article

References (15)

1. Allen JC, Walker R, Luks E, Jennings M, Barfoot S, Tan C. 1987. Carboplatin and recurrent childhood brain tumors. Journal of Clinical Oncology 5:459-463.
2. Al-Waili NS, Butler GJ. 2007. A combination of radiotherapy, nitric oxide and a hyperoxygenation sensitizing protocol for brain malignant tumor treatment. Medical Hypotheses 68:528-537.
3. Cecchelli R, Dehouck B, Descamps L, Fenart L, Buee-Scherrer V, Duhem C, Lundquist S, Rentfel M, Torpier G, Dehouck MP. 1999. In vitro model for evaluating drug transport across the blood-brain barrier. Advanced Drug Delivery Reviews 36:165-178.
4. Chougule PB, Akhtar MS, Akerley W, Ready N, Safran H, McRae R, Nigri P, Bellino J, Koness J, Radie-Keane K, et al. 1999. Chemoradiotherapy for advanced inoperable head and neck cancer: A phase II study. Seminars in Radiation Oncology 9(2 Suppl. 1):58-63.
5. Crofton KM, Makris SL, Sette WF, Mendez E, Raffaele KC. 2004. A qualitative retrospective analysis of positive control data in developmental neurotoxicity studies. Neurotoxicology and Teratology 26:345-352.
6. Culot M, Lundquist S, Vanuxeem D, Nion S, Landry C, Delplace Y, Dehouck MP, Berezowski V, Fenart L, Cecchelli R. 2008. An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening. Toxicology in Vitro 22:799-811.
7. Dehouck MP, Meresse S, Delorme P, Fruchart JC, Cecchelli R. 1990. An easier, reproducible, and mass-production method to study the blood-brain barrier in vitro. Journal of Neurochemistry 54:1798-1801.
8. Gottesman MM, Pastan I. 1993. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annual Reviews of Biochemistry 62:385-427.
9. Kalns J, Krock L, Piepmeier Jr E. 1998. The effect of hyperbaric oxygen on growth and chemosensitivity of metastatic prostate cancer. Anticancer Research 18:363-367.
10. Rump AF, Siekmann U, Kalff G. 1999. Effects of hyperbaric and hyperoxic conditions on the disposition of drugs: Theoretical considerations and a review of the literature. General Pharmacology 32:127-133.
11. Sarkadi B, Price EM, Boucher RC, Germann UA, Scarborough GA. 1992. Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. Journal of Biological Chemistry 267:4854-4858.
12. Tanaka K, Yoshida Y, Hashimoto T, Gamura S, Shimizu M, Aoyama T, Yamazaki H. 2005. Pharmacokinetics of anti-cancer drug with hyperbaric oxygenation therapy. Neuro-Oncology 15:7-10. [in Japanese].
13. Tanaka K, Yoshida Y, Hashimoto T, Suga M, Yoshida K. 2004. Statistical study of chemotherapy for malignant gliomas. Neuro-Oncology 14:15-18. [in Japanese].
14. Yamazaki H, Tanaka K, Gamura S, Hashimoto T, Shimizu M. 2006. High-performance liquid chromatographic assay for carboplatin in ultrafiltered plasma combined with hyperbaric oxygenation. Drug Metabolism and Pharmacokinetics 21:429-431.
15. Zhao P, Dash AK. 1999. A simple HPLC method using a microbore column for the analysis of doxorubicin. Journal of Pharmaceutical and Biomedical Analysis 20:543-548.